Results 61 to 70 of about 7,331 (198)
Cost‐Effectiveness of Ivabradine for Heart Failure in the United States
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016 BackgroundIvabradine is a heart rate–lowering agent approved to reduce the risk of hospitalization for worsening heart failure. This study assessed the cost‐effectiveness of adding ivabradine to background therapy in the United States from the ...
Anuraag R. Kansal +6 more
doaj +1 more source
, 2016 Heart rate (HR) lowering by β-blockade was shown to be beneficial after myocardial infarction. In contrast, HR lowering with ivabradine was found to confer no benefits in 2 prospective randomized trials in patients with coronary artery disease.
Rimoldi, Stefano +6 more
core +1 more source
Cardiovascular Health in Women—Across the Lifespan
Clinical Endocrinology, Volume 104, Issue 6, Page 539-555, June 2026.ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar +5 more
wiley +1 more source
ESC Heart FailureBackground Ivabradine, a medical treatment for heart failure (HF), reduces heart rate (HR) and prolongs diastolic perfusion time. It is frequently prescribed to patients with HF who have a suboptimal response or intolerance to beta‐blockers. Degenerative
Wei‐Chieh Lee +5 more
doaj +1 more source
Рациональная фармакотерапия в кардиологии, 2016 Aim. To study influence of ivabradine as compared with bisoprolol on clinical and hemodynamic indices, exercise tolerance, endothelial function, quality of life (QL) and erectile function in patients with ischemic heart disease. Material and methods.
R. D. Kurbanov +3 more
doaj +1 more source
pharma-kritik, 2008 Mit einer neuen Wirkungsweise erreicht Ivabradin eine ähnliche antianginöse Wirkung wie Atenolol oder Amlodipin. Als Prophylaxe gegen koronare Ereignisse scheint die teure Innovation jedoch nicht wirksam.
openaire +1 more source
Ivabradine in patients with heart failure: a systematic literature review
, 2023 Background: Heart failure is a chronic disease linked with significant morbidity and mortality, and uncontrolled resting heart rate is a risk factor for adverse outcomes. This systematic literature review aimed to assess the efficacy, safety, and patient-
Zeba M. Khan +4 more
core +1 more source
Ivabradine: beyond heart rate control.
, 2009 Chronic stable angina pectoris (CSAP) usually occurs in patients with coronary artery disease (CAD) that affects one or more large epicardial arteries. It results when myocardial perfusion is insufficient to meet cardiac metabolic demand.
D'Orazio N., Vitulano N, Riccioni G
core +1 more source
Ivabradine inhibits carbachol-induced contractions of isolated rat urinary bladder [PDF]
, 2018 KALKAN, Omer Faruk/0000-0002-7574-1183;Background. Overactive bladdei (OAB), a symptom syndrome defined as urgency, is a common clinical condition, which sometimes cannot be satisfactorily treated with current medications in every subject; therefoie ...
Aydın, Hasan Rıza +6 more
core +1 more source
, 2022 BackgroundHeart rate (HR) control is important in heart failure (HF) patients with reduced ejection fraction, and ivabradine is indicated for patients with chronic HF and sinus rhythm.
Jung-Jung Chang (4818144) +7 more
core +1 more source